Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Breathing and swallowing training for people with ALS

Official title: Combined Respiratory Training to Improve Pulmonary and Cough Function in Persons With ALS

Run by Nova Southeastern University · NCT05913882 · Data updated 2026-11-12

This study is testing if breathing and swallowing training can help people with ALS breathe better and improve their quality of life.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment34 (estimated)
SponsorNova Southeastern University
Academic / other
Locations1 site (Fort Lauderdale, Florida)
StatusRecruiting
StartedAugust 22, 2023
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2026
Registry record updatedDecember 23, 2025
Trial IDNCT05913882 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with probable or definite ALS within two years of symptom onset who have not previously undergone LVR or EMST training.

Probably not a fit

Patients with advanced cognitive impairment, tracheostomy, or those using invasive mechanical ventilation are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial aims to evaluate the effects of combined lung volume recruitment (LVR) and expiratory muscle strength training (EMST) on respiratory function and quality of life in patients diagnosed with ALS. The study will involve up to 39 participants who will undergo a series of assessments and telehealth therapy sessions to monitor cough strength, dyspnea, and overall well-being. Participants will serve as their own controls, allowing for a more accurate assessment of the treatment's impact over time. The trial includes both in-person evaluations and remote training sessions to ensure adherence and effectiveness.

Why it matters

Potential benefit: If successful, this approach could improve respiratory function and quality of life for patients with ALS.

How similar studies have gone: While similar approaches have been explored, this specific combination of LVR and EMST in ALS patients is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. A diagnosis of probable or definite ALS in accordance with the Revisited El-Escorial Criteria.
2. Disease duration from symptom onset of ≤ 2 years,
3. Lung volume recruitment and expiratory muscle strength training naïve,
4. Reduced peak cough flow (% predicted for age and gender).

Exclusion Criteria:

1. History of stroke, head and neck cancer or other concomitant disorder that might contribute to dysphagia or respiratory impairment.
2. Use of prescription cough assist or non-invasive volume ventilation devices.
3. Enrollment in another research investigation that might impact cough or respiratory function.
4. Diagnosis of frontotemporal dementia or advanced cognitive impairment.
5. Tracheostomy placement/Use of invasive mechanical ventilation.
6. Contraindications for respiratory training (i.e., history of pneumothorax, severe chronic obstructive pulmonary disease).

Where it's running

  • Nova Southeastern University
    Fort Lauderdale, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.